The global asthma treatment market is poised for significant growth, driven by rising asthma cases and advancements in treatment options. This report analyzes market trends, key players, and future projections, highlighting the emergence of biologics and personalized therapies.
The Indian Medical Association (IMA) has written to the Union Health Minister, expressing concerns over the delay in NEET PG 2024 counselling due to a pending Supreme Court case. The IMA emphasizes the impact of the delay on aspiring doctors and the healthcare system, urging the government to explore interim measures to expedite the counselling process.
This article explores the concept of oversold stocks in the healthcare sector, focusing on three companies: Nkarta Inc (NKTX), Moderna Inc (MRNA), and AMN Healthcare Services (AMN). It analyzes their recent performance, RSI values, and potential future prospects, highlighting potential buying opportunities for investors seeking undervalued companies.
Accolade Inc., a personalized healthcare company, exceeded expectations for its second quarter of fiscal year 2025, reporting a revenue increase of 10% and a narrower adjusted EBITDA loss. The company also provided guidance for the third quarter and full fiscal year, indicating a path toward profitability. Despite the positive earnings, Accolade’s stock has significantly declined this year, with analysts lowering their price targets.
The global anti-infective drugs market is projected to experience substantial growth, reaching US$ 177.9 billion by 2031, driven by factors such as the increasing prevalence of infectious diseases, rising awareness of hygiene and prevention, advancements in drug development, and the growing threat of antimicrobial resistance.
RADPAIR, a leader in generative AI-driven radiology reporting, has announced the launch of RADPAIR 2.0, powered by Groq’s LPU AI inference technology. This next-generation platform features a new user interface and a suite of advanced tools designed to enhance speed, accuracy, and efficiency in radiology workflows.
The Indian Medical Association (IMA) has expressed concern over the delayed NEET PG 2024 counselling process, highlighting the distress it is causing to thousands of aspiring doctors. The IMA has urged the Union Health Minister to take immediate action to ensure the counselling process begins, safeguarding the interests of both students and the healthcare system.
The global antibody production market is experiencing significant growth, driven by increasing prevalence of cancer and autoimmune disorders. The market size is projected to reach US$ 30.7 billion by 2031, driven by the demand for monoclonal antibodies (mAbs) for targeted treatments and the rising need for tailored therapies.
Labcorp Holdings (LH) is poised for long-term growth through strategic investments in cell and gene therapy, expansion into the consumer market, and international growth. The company faces headwinds from macroeconomic uncertainties and currency fluctuations, but its cost-saving initiatives and strong performance in key areas position it for continued success.
The global spine surgery robots market is poised for significant growth, projected to reach US$ 525.3 Mn by 2031, driven by the increasing prevalence of spinal disorders, advancements in robotic technology, and a growing preference for minimally invasive surgeries. These robots offer surgeons enhanced precision, improved outcomes, and reduced recovery times for patients.
